Definitions
Sorry, no definitions found. You may find more data at dendreon.
Etymologies
Sorry, no etymologies found.
Support
Help support Wordnik (and make this page ad-free) by adopting the word Dendreon.
Examples
-
Several Arena shareholders said they had also invested in Dendreon, whose stock soared after the FDA approval.
FDA to Decide Obesity Drug Lorcaserin's Fate Alicia Mundy 2010
-
Provenge is derived from a patient's own immune system (dendritic cells, hence the name Dendreon) and is poised (upon FDA approval) to become the first of a new class of therapeutics called active cellular immunotherapies (ACI) which are also referred to as therapeutic cancer vaccines.
-
Provenge is derived from a patient's own immune system (dendritic cells, hence the name Dendreon) and is poised (upon FDA approval) to become the first of a new class of therapeutics called active cellular immunotherapies (ACI) which are also referred to as therapeutic cancer vaccines.
-
As late as May 7, 2007, Prohost Biotechnology, a firm that evaluates companies and publishes a monthly newsletter for investors, was calling Dendreon a good investment on its web site, stating: We Have A New Pick "DENDERON AGAIN."
-
While the positive fundamentals are there, this month small cap biotech stocks have suffered from what MarketWatch's Val Brickates Kennedy calls the "Dendreon Effect."
unknown title 2011
-
While the positive fundamentals are there, this month biotech stocks have suffered from what MarketWatch's Val Brickates Kennedy calls the "Dendreon Effect."
unknown title 2011
-
He sees companies such as Dendreon and Rigel Pharmaceuticals Inc., which has a drug for rheumatoid arthritis in development, as ripe for partnership agreements or acquisitions.
-
Conversely, if you'd labeled yourself "aggressive," you might have been told about an up-and-coming small cap such as Dendreon (Nasdaq: DNDN), or an emerging-markets play such as
-
Conversely, if you'd labeled yourself "aggressive," you might have been told about an up-and-coming small cap such as Dendreon (Nasdaq: DNDN), or an emerging-markets play such as
-
Following additional research and pressure from investors in Provenge maker Dendreon Corp., the FDA approved Provenge in April of this year.
FDA to Decide Obesity Drug Lorcaserin's Fate Alicia Mundy 2010
Comments
Log in or sign up to get involved in the conversation. It's quick and easy.